Press release
Crohn's Disease Treatment Pipeline Shows Strong Momentum as 90+ Pharma Companies in the Race | DelveInsight
DelveInsight's, "Crohn's Disease Pipeline Insight 2026" report provides comprehensive insights about 90+ companies and 90+ pipeline drugs in Crohn's Disease pipeline landscape. It covers the Crohn's Disease pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Crohn's Disease pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.Stay ahead in understanding the Crohn's Disease Treatment Landscape @ https://www.delveinsight.com/sample-request/crohns-disease-pipeline-insight [https://www.delveinsight.com/sample-request/crohns-disease-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Crohn's Disease Pipeline Report
* On April 15, 2026- AbbVie initiated a phase 3 study will assess how safe and effective oral Upadacitinib is in treating moderately to severely active Crohn's Disease in pediatric participants aged 2 to 18 years old who have had inadequate response, loss of response, intolerance, or medical contraindications to corticosteroids, immunosuppressants, and/or biologic therapy.
* On April 13, 2026- Janssen-Cilag Ltd . conducted a phase 3b study is to evaluate the efficacy of guselkumab in healing of all layers of the digestive tract (transmural healing) with the help of a score called Magnetic Resonance Index of Activity (MaRIA) based on a scan at Week 48.
* On April 13, 2026- Merck Sharp & Dohme LLC initiated a phase 3 Study 1's primary hypotheses are that at least 1 tulisokibart dose level is superior to placebo in the proportion of participants achieving clinical remission per Crohn's Disease Activity Index score (
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Crohn's Disease Treatment Pipeline Shows Strong Momentum as 90+ Pharma Companies in the Race | DelveInsight here
News-ID: 4475381 • Views: …
More Releases from ABNewswire
Tundrr Carbon-Based Soil Conditioner for Global Buyers: Specification-Led Sourci …
Tundrr Carbon-Based Soil Conditioner provides global buyers with a specification-led soil-improvement sourcing option from China. Formulated with greater than or equal to 35% organic matter, greater than or equal to 25% biochar, plus defined calcium, silicon, and magnesium content, it is designed for soil-structure and acidic-soil management programs. Tundrr supports quality control and export coordination for agricultural buyers.
As growers, agricultural distributors, private-label programs, and soil-management projects place greater emphasis on…
ROAM Roof & Solar Launches Radiant Barrier Service as Central Texas Homeowners S …
As ERCOT forecasts record power demand across Texas this summer, Belton-based ROAM Roof & Solar has launched a radiant barrier program backed by U.S. Department of Energy testing - aimed at helping homeowners reduce attic heat and ease the strain on rising electric bills.
BELTON, Texas - July 30, 2026 - ROAM Roof & Solar, a veteran-owned roofing, siding, gutters, solar, and waterproofing company, today announced the launch of its radiant…
Sunbird Carpet Cleaning of Columbia Says One Red Wine Spill Still Stands Out Aft …
The call came on a Tuesday morning from a homeowner in Columbia's Hickory Ridge neighborhood. Friends had gathered over the weekend, someone tipped over a glass of Cabernet, and red wine soaked into a light-colored living room carpet. The family reached for paper towels, club soda, and a grocery-store stain remover. Three days later, the stain had grown darker, the carpet felt stiff, and the spill had spread well beyond…
Baltimore Carpet & Upholstery Finds a Home Office Frozen in Time Beneath One Des …
The desk hadn't moved in nearly five years. When a Roland Park homeowner finally rolled it aside before a scheduled carpet cleaning, technicians from Baltimore Carpet & Upholstery uncovered something few people expect to see: a detailed record of thousands of workdays preserved in the carpet since 2020.
A software engineer living in Baltimore's Roland Park neighborhood scheduled a carpet cleaning after deciding to reclaim a spare bedroom that had served…
More Releases for Crohn
Global IBD Ulcerative Colitis And Crohn S Disease Treatment Industry Poised for …
The IBD Ulcerative Colitis And Crohn S Disease Treatment Market research report offers crucial insights into how the industry is evolving, highlighting key drivers of growth and the main revenue streams expected between 2024 and 2032. Similar to a compass, it helps businesses navigate the market's complexities by showcasing both the present situation and the newest developments influencing its direction. For businesses, stakeholders, and industry participants, this report serves as…
Global Companion Animal Specialty Drugs and Crohn s Disease Drug (COVID-19 Imapa …
The Companion Animal Specialty Drugs Market ( https://bit.ly/31KDIZZ ) report is intended to function as a supportive means to assess the Companion Animal Specialty Drugs market along with the complete analysis and clear-cut statistics related to this market. In other words, the report would provide an up-to-date study of the market in terms of its latest trends, present scenario, and the overall market situation. Further, it will also help the…
Crohn’s Disease Drugs Market Research and Clinical Analysis 2020 - Bayer AG, Amg …
The Crohn's Disease Drugs Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Order a Copy of…
Crohn s Disease Drug Market to Witness Huge Growth by 2025 | AbbVie, Janssen Bio …
HTF MI recently introduced Global Crohn s Disease Drug Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are AbbVie, Janssen Biotech, UCB, Amgen, Tillotts Pharma & Takeda…
Crohn Disease Market 2018 by its Scientific Reviews, Clinical Application and Ke …
Global Crohn Disease Market Professional Survey Report 2018 to 2025 presents an in-depth assessment of the Crohn Disease Market including enabling key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents forecasts for Crohn Disease Market investments from 2018 till 2025.
This study answers several questions for stakeholders, primarily which market segments…
Crohn Disease Market Set for Expansive Growth by 2022
This report studies the global Crohn Disease market, analyzes and researches the Crohn Disease development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Johnson & Johnson
Pfizer
Sanofi
Merck
GSK
AbbVie
Takeda
Ferring
UCB
Boehringer Ingelheim
Ask for sample copy @ http://www.researchtrades.com/request-sample/1117798
Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia
Market segment by Type, Crohn Disease can be split into
Small Intestine and Ileocephalitis
Colon Disease
Market segment…
